NCATS Eli Lilly Externship Program Announcement – 2019 Cycle

NCATS Eli Lilly Externship Program Announcement – 2019 Cycle

NCATS and Eli Lilly are accepting applications for its next round of Lilly externship program. This 6 month externship aims to increase the skill sets of translational science trainees in drug development and to learn from another sector in the translational research ecosystem. As you know, NCATS continues to promote innovative partnerships among different stakeholders in translation.

Please see the link below that describes the purpose and goals of the externship, and how to submit an application. In addition, there is now a ‘live’ video vignette from an alumni that shares her feedback on the program.


This externship opportunity is open to CTSA Program trainees, scholars or investigators supported by CTSA Program hub award* funds who:

  • Have a clinical doctoral degree (M.D. or Ph.D.) or its equivalent in biological or biomedical sciences, bioengineering or a related field;
  • Have a record of accomplishments in clinical and translational science research;
  • Have a keen interest in learning more about drug development and commercialization processes; and
  • Are U.S. citizens or permanent residents of the United States.

*Typically, candidates should fit into one of the following three categories:

  • CTSA investigators supported under the UL1
  • CTSA Program TL1 Trainee, postdoctoral level
  • CTSA Program KL2 scholar (if built in upfront in career development plan)

It is expected that at the end of this externship that participants (coming from academia) will understand the work, “language” and culture of another part of the translational ecosystem (industry) and contribute to the growth of an interdisciplinary translational workforce that can promote cooperation and collaboration among academic and industry stakeholders.

Lilly will identify projects that selected participants will have the opportunity in which to work. Due to the confidential nature of the work being done at Eli Lilly, selected candidates will need to sign a non-disclosure agreement should a scholar/trainee from your institution be selected. However, this externship doesn’t preclude publication of non-confidential results.

Online applications must be received by April 16th, 2019. Application materials should be submitted by the Authorized Organization Representative (AOR) via email to

Please share widely with your CTSA supported early career researchers under the UL1, TL1 trainees and KL2 scholars.

Please contact Dr. Joan Nagel with any questions


Add Your Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.